Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription 27.05.2024 1 AIDS 2 Ann Intern Med 2 BMC Pediatr 2 J Infect 1 J Infect Dis 1 J Virol 4 JAMA 1 Lancet 1 MMWR Morb Mortal Wkly Rep 2 Pediatrics 9 PLoS One 1 Proc Natl Acad Sci U S A 1 Science 23 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. JONGKEES MJ, Tan NH, Geers D, de Vries RD, et al
   Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
   AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003933.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. 
   Notice of Retraction: Measles, Mumps, Rubella Vaccination and Autism.
   Ann Intern Med. 2024 May 21. doi: 10.7326/ANNALS-24-00530.
   PubMed        
   
   
3. COSCHI CH, Dodbiba L, Guerry D
   Oncology: What You May Have Missed in 2023.
   Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0520.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

4. LAKER G, Nankunda J, Melvis BM, Kajoba D, et al
   Prevalence and factors associated with rotavirus diarrhea among children aged 3-24 months after the introduction of the vaccine at a referral hospital in Uganda: a cross-sectional study.
   BMC Pediatr. 2024;24:358.
   PubMed         Abstract available
   
   
5. SARBAZI E, Masoudi N, Mehri A, Esfanjani RM, et al
   Trust in primary health care and COVID-19 vaccine uptake among Iranian pediatric: a web-based cross-sectional survey.
   BMC Pediatr. 2024;24:356.
   PubMed         Abstract available
   
   

   
   J Infect

6. PATERNINA-CAICEDO A, Quevedo DS, Rios DS, Moyano D, et al
   Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.
   J Infect. 2024;88:106165.
   PubMed        
   
   
7. TSANG RSW, Deceuninck G, Meilleur C, Zhou J, et al
   Temporal variations in the serogroup distribution of invasive meningococcal disease in Quebec, Canada, due to emerging unique clade of serogroup Y strain belonging to the Sequence Type-23 clonal complex.
   J Infect. 2024;88:106163.
   PubMed         Abstract available
   
   

   
   J Infect Dis

8. TOWNSEND L, Gillespie P, McGrath J, Kenny C, et al
   Health Care Personnel Workdays Lost and Direct Health Care Salary Costs Incurred due to COVID-19 Infection in the Age of Widespread Vaccine Availability.
   J Infect Dis. 2024 May 21:jiae223. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

9. HASHIZUME M, Takashima A, Iwasaki M
   An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.
   J Virol. 2024 May 20:e0057824. doi: 10.1128/jvi.00578.
   PubMed         Abstract available
   
   

   
   JAMA

10. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed        
    
    
11. HARRIS E
    Microneedle Vaccine Patches Generated Immune Response in Children.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
    PubMed        
    
    
12. QATO DM, Romley JA, Myerson R, Goldman D, et al
    Shingles Vaccination in Medicare Part D After Inflation Reduction Act Elimination of Cost Sharing.
    JAMA. 2024 May 23. doi: 10.1001/jama.2024.7348.
    PubMed        
    
    
13. HARRIS E
    CDC Warns of Surge in Meningococcal Disease in US.
    JAMA. 2024;331:1614.
    PubMed        
    
    

    
    Lancet

14. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
    Cofinancing immunisation through national health insurance.
    Lancet. 2024;403:1983-1984.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

15. GUAGLIARDO SAJ, Kracalik I, Carter RJ, Braden C, et al
    Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine - United States, May 2022-May 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:460-466.
    PubMed         Abstract available
    
    

    
    Pediatrics

16. DAWSON-HAHN E, Green AE
    Applying a Cultural Safety Framework to Understand Vaccination of Children in Immigrant Families.
    Pediatrics. 2024 May 22:e2023065190. doi: 10.1542/peds.2023-065190.
    PubMed        
    
    
17. TASSLIMI A, Bell TR, Moore TP, DeBolt C, et al
    Vaccine Coverage at 36 Months and 7 Years by Parental Birth Country, Washington State.
    Pediatrics. 2024 May 22:e2023064626. doi: 10.1542/peds.2023-064626.
    PubMed         Abstract available
    
    

    
    PLoS One

18. BRIZUELA M, Palermo MC, Alconada T, Sandoval MM, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae in Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297767.
    PubMed         Abstract available
    
    
19. LIU Y, Zhang C, Wang Y, Luo X, et al
    Seroepidemiology of pertussis in Huzhou: A population-based, cross-sectional study.
    PLoS One. 2024;19:e0303508.
    PubMed         Abstract available
    
    
20. YOSHIMURA M, Honda Y, Yonemitsu E, Kuraoka K, et al
    Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
    PLoS One. 2024;19:e0301688.
    PubMed         Abstract available
    
    
21. LOPEZ-CODONY V, de Andres-Pablo A, Ferrando-Diez A, Fernandez-Montoli ME, et al
    Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol.
    PLoS One. 2024;19:e0304080.
    PubMed         Abstract available
    
    
22. TRZEBINSKI W, Trzebinski J
    Correction: How does collectivism help deal with perceived vaccine artificiality? The case of COVID-19 vaccination intent in European young adults.
    PLoS One. 2024;19:e0304372.
    PubMed         Abstract available
    
    
23. KASZTELEWICZ B, Skrok K, Burzynska J, Migdal M, et al
    Incidence of SARS-CoV-2 infection among healthcare workers before and after COVID-19 vaccination in a tertiary paediatric hospital in Warsaw: A retrospective cohort study.
    PLoS One. 2024;19:e0301612.
    PubMed         Abstract available
    
    
24. COBB J, Rawson J, Gonzalez N, Orr C, et al
    Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
    PLoS One. 2024;19:e0303863.
    PubMed         Abstract available
    
    
25. BROSHKEVITCH CJ, Barnabas RV, Liu G, Palanee-Phillips T, et al
    Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
    PLoS One. 2024;19:e0301997.
    PubMed         Abstract available
    
    
26. HURST JH, Shaik-Dasthagirisaheb YB, Truong L, Boiditswe SC, et al
    Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016-2019).
    PLoS One. 2024;19:e0302400.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

27. WU C, Raheem IT, Nahas DD, Citron M, et al
    Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
    Proc Natl Acad Sci U S A. 2024;121:e2317230121.
    PubMed         Abstract available
    
    

    
    Science

28. COHEN J
    A bird flu vaccine for cows? It's complicated.
    Science. 2024;384:837-838.
    PubMed         Abstract available
    
    

    
    Vaccine

29. TSAMPALIEROS A, Zemek R, Barrowman N, Langlois MA, et al
    Hybrid immunity after BNT162b2 Covid-19 vaccine administration in children aged 5 to 11 years.
    Vaccine. 2024 May 23:S0264-410X(24)00588-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
30. BENEDICT KPOZEHOUEN E, Raina Macintyre C, Tan TC
    Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community.
    Vaccine. 2024 May 23:S0264-410X(24)00619-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
31. EIBERG MF, Rezahosseini O, Bukan KB, Charlotte Arp B, et al
    Changes in vaccination uptake against pneumococcal disease, influenza, and coronavirus disease 2019 (COVID-19) before and after a Head and Neck cancer diagnosis.
    Vaccine. 2024 May 23:S0264-410X(24)00566-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
32. KANDASAMY R, Gurung M, Shrestha S, Gautam MC, et al
    Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study.
    Vaccine. 2024 May 23:S0264-410X(24)00564-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
33. YEGANEH N, Yin S, Moir O, Danza P, et al
    Effectiveness of JYNNEOS vaccine against symptomatic mpox disease in adult men in Los Angeles County, August 29, 2022 to January 1, 2023.
    Vaccine. 2024 May 23:S0264-410X(24)00594-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
34. PROSPER P, Rodriguez Puertas R, Guerin DMA, Branda MM, et al
    Computational method for designing vaccines applied to virus-like particles (VLPs) as epitope carriers.
    Vaccine. 2024 May 22:S0264-410X(24)00584-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
35. ZHOU H, Zhao W, Ma R, Zheng Y, et al
    Mixed methods examination of risk perception on vaccination intentions: The perspective of doctor-patient communication.
    Vaccine. 2024 May 22:S0264-410X(24)00565-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
36. PAN X, Guo X, Shi J
    Design of a novel multiepitope vaccine with CTLA-4 extracellular domain against Mycoplasma pneumoniae: A vaccine-immunoinformatics approach.
    Vaccine. 2024 May 21:S0264-410X(24)00568-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
37. ZHANG WX, Zhang Y, Du J, Shi W, et al
    Effectiveness of momentary intervention on influenza vaccination among the elderly in China: From willingness to action.
    Vaccine. 2024 May 22:S0264-410X(24)00591-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
38. DO LAH, Le NTN, Mahmud S, Mulholland K, et al
    Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling study.
    Vaccine. 2023;41:6782-6790.
    PubMed         Abstract available
    
    
39. UGHASORO MD, Nnakenyi I, Echendu N, Akpeh JO, et al
    Neutralizing anti-polio antibody titre in newborn babies in post-polio eradication period in Nigeria.
    Vaccine. 2023;41:6820-6823.
    PubMed         Abstract available
    
    
40. KUPEK E
    Avoidable COVID-19-related deaths and hospitalizations in Brazil, 2020-2023.
    Vaccine. 2024;42:3437-3444.
    PubMed         Abstract available
    
    
41. TRINITE B, Durr E, Pons-Grifols A, O'Donnell G, et al
    VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
    Vaccine. 2024 Apr 18:S0264-410X(24)00473-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
42. GRIFFIN I, Berry I, Navarra T, Priyamvada L, et al
    Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.).
    Vaccine. 2024 May 17:S0264-410X(24)00563-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
43. KIM S, Choi JK, Suh J, Park SH, et al
    The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study.
    Vaccine. 2024 May 17:S0264-410X(24)00562-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
44. YANG T, Tong F, Tang L, Li P, et al
    Repeated vaccination does not appear to significantly weaken the protective effect of influenza vaccine in the elderly: A test-negative case-control study in China.
    Vaccine. 2024 May 17:S0264-410X(24)00593-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
45. ANN COSTA CLEMENS S, Weckx L, Milan EP, Smolenov I, et al
    Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice.
    Vaccine. 2024 May 17:S0264-410X(24)00555-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
46. TSUJII A, Takahashi K, Harada H, Kawashima S, et al
    Evaluation of the protective effect of the intranasal vaccines adjuvanted with bacterium-like particles against intestinal infection.
    Vaccine. 2024 May 18:S0264-410X(24)00582-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
47. GARG R, Liu Q, Van Kessel J, Asavajaru A, et al
    Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.
    Vaccine. 2024 May 19:S0264-410X(24)00586-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
48. KARIMI-SHAHRBABAK E, Di Chiara C, Farrar DS, Abu Fadaleh SM, et al
    COVID-19 vaccine acceptance and uptake among caregivers of children aged 5-11?years in Ontario, Canada: A cross-sectional survey.
    Vaccine. 2024 May 20:S0264-410X(24)00553-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
49. CHIHANA R, Jin Kee J, Moodie Z, Huang Y, et al
    Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702.
    Vaccine. 2024 May 21:S0264-410X(24)00598-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
50. MACHIDA M, Fukushima S, Saitoh A, Inoue S, et al
    Uptake among four indicated vaccines by adults aged 65 years and older in Japan, 2023.
    Vaccine. 2024 May 20:S0264-410X(24)00592-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
51. VAN DER PLAS JL, Haijema BJ, Leenhouts K, Paul Zoeteweij J, et al
    Safety, reactogenicity and immunogenicity of an intranasal seasonal influenza vaccine adjuvanted with gram-positive matrix (GEM) particles (FluGEM): A randomized, double-blind, controlled, ascending dose study in healthy adults and elderly.
    Vaccine. 2024 May 20:S0264-410X(24)00370-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

    
    Virology

52. SHAO J, Liu W, Gao S, Chang H, et al
    A recombinant multi-epitope trivalent vaccine for foot-and-mouth disease virus serotype O in pigs.
    Virology. 2024;596:110103.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.